Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-08

Clinical Trial Update: Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients [NA]

View source ↗

Summary

A University of Jena clinical trial is investigating regional kale as a source of lutein and zeaxanthin to improve vision in age-related macular degeneration. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Jena | Conditions: Changes in Macular Pigment Optical Density | NA | Status: UNKNOWN